Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish

Autor: Xiaolei Xu, Wang Lei, René R. Sevag Packard, Yong Wang, Alexey V. Dvornikov, Tzung K. Hsiai, Matthew R. Lowerison, Yonghe Ding, Yuji Zhang, Xiao Ma, Zhang Hong, Jun Chen, Xueying Lin
Rok vydání: 2019
Předmět:
0301 basic medicine
Mutant
Neuroscience (miscellaneous)
lcsh:Medicine
Medicine (miscellaneous)
Haploinsufficiency
Biology
BAG3
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
0302 clinical medicine
Immunology and Microbiology (miscellaneous)
Transcription Activator-Like Effector Nucleases
mtor
lcsh:Pathology
Animals
Amino Acid Sequence
Zebrafish
Mechanistic target of rapamycin
PI3K/AKT/mTOR pathway
Adaptor Proteins
Signal Transducing

Transcription activator-like effector nuclease
Base Sequence
Gene Expression Profiling
Myocardium
TOR Serine-Threonine Kinases
lcsh:R
Zebrafish Proteins
Zebra
biology.organism_classification
Cell biology
dilated cardiomyopathy
Phenotype
030104 developmental biology
Proteostasis
danio rerio
Mutation
bcl2-associated athanogene 3
biology.protein
Apoptosis Regulatory Proteins
Cardiomyopathies
030217 neurology & neurosurgery
Research Article
Signal Transduction
lcsh:RB1-214
Zdroj: Disease Models & Mechanisms, Vol 12, Iss 10 (2019)
Disease Models & Mechanisms
ISSN: 1754-8411
1754-8403
Popis: The adult zebrafish is an emerging vertebrate model for studying human cardiomyopathies; however, whether the simple zebrafish heart can model different subtypes of cardiomyopathies, such as dilated cardiomyopathy (DCM), remains elusive. Here, we generated and characterized an inherited DCM model in adult zebrafish and used this model to search for therapeutic strategies. We employed transcription activator-like effector nuclease (TALEN) genome editing technology to generate frame-shift mutants for the zebrafish ortholog of human BCL2-associated athanogene 3 (BAG3), an established DCM-causative gene. As in mammals, the zebrafish bag3 homozygous mutant (bag3e2/e2) exhibited aberrant proteostasis, as indicated by impaired autophagy flux and elevated ubiquitinated protein aggregation. Through comprehensive phenotyping analysis of the mutant, we identified phenotypic traits that resembled DCM phenotypes in mammals, including cardiac chamber enlargement, reduced ejection fraction characterized by increased end-systolic volume/body weight (ESV/BW), and reduced contractile myofibril activation kinetics. Nonbiased transcriptome analysis identified the hyperactivation of the mechanistic target of rapamycin (mTOR) signaling in bag3e2/e2 mutant hearts. Further genetic studies showed that mtorxu015/+, an mTOR haploinsufficiency mutant, repaired abnormal proteostasis, improved cardiac function and rescued the survival of the bag3e2/e2 mutant. This study established the bag3e2/e2 mutant as a DCM model in adult zebrafish and suggested mtor as a candidate therapeutic target gene for BAG3 cardiomyopathy.
Summary: This study shows that adult bag3 knockout mutant zebrafish can be used as a model for DCM, and haploinsufficiency of mTOR is cardioprotective.
Databáze: OpenAIRE